The Journal of Organic Chemistry
Article
(3,6-Bis(4-nitrophenyl)-5,6-dihydropyridazin-1(4H)-yl)(phenyl)-
methanone (4g). The representative procedure was followed using
N′-(2-bromo-1-(4-nitrophenyl) ethylidene) benzohydrazide (1j) (0.5
mmol) as the substrate. Isolation by column chromatography (PE/
EtOAc: 5:1) yielded 4g (75 mg, 70%) as a yellow solid. Mp = 71.2−
N′-(2-bromo-1-(4-cyanophenyl)ethylidene)-4-chlorobenzohydrazide
(1q) (0.5 mmol) as the substrate. Isolation by column chromatog-
raphy (PE/EtOAc: 5:1) yielded 4l (79 mg, 75%) as a yellow solid.
Mp = 89.3−91.2 °C. 1H NMR (400 MHz, CDCl3): δ ppm 7.75 (d, J
= 8 Hz, 2H), 7.67−7.63 (m, 6H), 7.46 (d, J = 8 Hz, 2H), 7.26 (d, J =
8 Hz, 2H), 6.07 (s, 1H), 2.76−2.71 (m, 1H), 2.47−2.33 (m, 2H),
2.24−2.12 (m, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ ppm
169.1, 145.4, 144.9, 140.5, 137.3, 132.9, 132.4, 131.5, 128.0, 126.2,
125.8, 118.3, 112.9, 111.8, 52.0, 23.5, 18.6. HRMS (ESI-Q-TOF)
exact mass calcd for C25H18ClN4O [M + H]+ 425.1169, found
425.1201.
(3,6-Bis(4-nitrophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-
chlorophenyl)methanone (4m). The representative procedure was
followed using N′-(2-bromo-1-(4-nitrophenyl)ethylidene)-4-chloro-
benzohydrazide (1r) (0.2 mmol) as the substrate. Isolation by column
chromatography (PE/EtOAc: 5:1) yielded 4m (89 mg, 77%) as a
yellow solid. Mp = 205.9−207.6 °C. 1H NMR (400 MHz, CDCl3): δ
ppm 7.75 (d, J = 8 Hz, 2H), 7.48−7.41 (m, 8H), 7.02 (d, J = 8 Hz,
2H), 5.98 (s, 1H), 2.69−2.64 (m, 1H), 2.39−2.25 (m, 2H), 2.21−
2.12 (m, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ ppm 169.0,
146.4, 138.7, 136.7, 135.6, 133.1, 132.0, 131.7, 131.6, 127.8, 127.2,
126.9, 123.9, 121.3, 51.4, 23.7, 18.6. HRMS (ESI-Q-TOF) exact mass
calcd for C23H18ClN4O5 [M + H]+ 465.0865, found 465.0842.
(3,6-Bis(4-chlorophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-(tert-
butyl)phenyl)methanone (4n). The representative procedure was
followed using N′-(2-bromo-1-(4-chlorophenyl)ethylidene)-4-(tert-
butyl)benzohydrazide (1s) (0.5 mmol) as the substrate. Isolation by
column chromatography (PE/EtOAc: 5:1) yielded 4n (98 mg, 85%)
as a yellow solid. Mp = 249.6−251.3 °C. 1H NMR (400 MHz,
CDCl3): δ ppm 7.78 (d, J = 8 Hz, 2H), 7.53 (d, J = 8 Hz, 2H), 7.47
(d, J = 8 Hz, 2H), 7.30−7.27 (m, 4H), 7.09 (d, J = 8 Hz, 2H), 6.03 (s,
1H), 2.68−2.63 (m, 1H), 2.39−2.26 (m, 2H), 2.21−2.10 (m, 1H),
1.38 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ ppm 170.0, 154.1,
145.7, 138.4, 135.5, 135.2, 133.1, 131.7, 130.1, 129.0, 128.6, 126.9,
126.7, 124.4, 51.3, 34.9, 31.2, 29.7, 23.8, 18.6. HRMS (ESI-Q-TOF)
exact mass calcd for C27H27Cl2N2O [M + H]+ 465.1501, found
465.1480.
1
73.5 °C. H NMR (400 MHz, CDCl3): δ ppm 8.22−8.16 (m, 4H),
7.80 (d, J = 8 Hz, 2H), 7.71 (d, J = 8 Hz, 2H), 7.57−7.48 (m, 3H),
7.34 (d, J = 8 Hz, 2H), 6.15 (s, 1H), 2.81−2.75 (m, 1H), 2.54−2.38
(m, 2H), 2.24−2.15 (m, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ
ppm 170.4, 148.1, 147.5, 147.0, 144.6, 142.4, 134.1, 131.1, 130.0,
127.7, 126.5, 126.1, 124.3, 123.8, 51.8, 29.7, 23.6, 18.7. HRMS (ESI-
Q-TOF) exact mass calcd for C23H19N4O5 [M + H]+ 431.1356, found
431.1327.
(3,6-Bis(4-fluorophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-
methoxyphenyl)methanone (4h). The representative procedure was
followed using N′-(2-chloro-1-(4-fluorophenyl)ethylidene)-4-methox-
ybenzohydrazide (1m) (0.5 mmol) as the substrate. Isolation by
column chromatography (PE/EtOAc: 5:1) yielded 4h (73 mg, 72%)
as a yellow solid. Mp = 71.8−72.6 °C. 1H NMR (400 MHz, CDCl3):
δ ppm 7.86 (d, J = 8 Hz, 2H), 7.63−7.59 (m, 2H), 7.14−7.11 (m,
2H), 7.04−6.94 (m, 6H), 6.03 (s, 1H), 3.89 (s, 3H), 2.69−2.64 (m,
1H), 2.39−2.25 (m, 2H), 2.22−2.13 (m, 1H). 13C{1H} NMR (100
1
MHz, CDCl3): δ ppm 169.4, 163.4 (d, JC4−F = 248.1 Hz), 162.0 (d,
1JC−F = 243.9 Hz), 161.5, 145.6, 135.6 (d, JC−F = 3.3 Hz), 133.3 (d,
4JC−F = 3.2 Hz), 132.5, 127.2 (d, 3JC−F = 8.3 Hz), 127.1 (d, 3JC−F = 8.0
2
2
Hz), 115.7 (d, JC−F = 21.5 Hz), 115.4 (d, JC−F = 21.6 Hz), 112.7,
55.4, 51.2, 29.7, 24.0, 18.7. 19F NMR (376 MHz, CDCl3) δ (ppm)
−111.7, −115.5. HRMS (ESI-Q-TOF) exact mass calcd for
C24H21F2N2O2 [M + H]+ 407.1571, found 407.1557.
(3,6-Bis(4-bromophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-
methoxyphenyl)methanone (4i). The representative procedure was
followed using N′-(2-bromo-1-(4-bromophenyl)ethylidene)-4-me-
thoxybenzohydrazide (1n) (0.5 mmol) as the substrate. Isolation by
column chromatography (PE/EtOAc: 5:1) yielded 4i (107 mg, 82%)
as a yellow solid. Mp = 185.2−187.4 °C. 1H NMR (400 MHz,
CDCl3): δ ppm 7.85 (d, J = 8 Hz, 2H), 7.50−7.42 (m, 6H), 7.03 (d, J
= 8 Hz, 2H), 6.96 (d, J = 8 Hz, 2H), 5.99 (s, 1H), 3.89 (s, 3H), 2.68−
2.62 (m, 1H), 2.39−2.24 (m, 2H), 2.22−2.11 (m, 1H). 13C{1H}
NMR (100 MHz, CDCl3): δ ppm 182.1, 169.2, 165.0, 162.0, 144.4,
141.8, 135.5, 133.3, 132.5, 132.0, 131.6, 127.1, 126.5, 123.7, 121.5,
114.4, 112.8, 85.9, 55.6, 31.8, 18.0. HRMS (ESI-Q-TOF) exact mass
calcd for C24H21Br2N2O2 [M + H]+ 528.9951, found 528.9954.
(3,6-Bis(4-methoxyphenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-
chlorophenyl)methanone (4j). The representative procedure was
followed using N′-(2-bromo-1-(4-methoxyphenyl) ethylidene)-4-
chlorobenzohydrazide (1o) (0.5 mmol) as the substrate. Isolation
by column chromatography (PE/EtOAc: 5:1) yielded 4j (85 mg,
(3,6-Bis(4-bromophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-(tert-
butyl)phenyl)methanone (4o). The representative procedure was
followed using N′-(2-bromo-1-(4-chlorophenyl)ethylidene)-4-(tert-
butyl)benzohydrazide (1t) (0.5 mmol) as the substrate. Isolation by
column chromatography (PE/EtOAc: 5:1) yielded 4o (113 mg, 82%)
as a white solid. Mp = 192.4−196.5 °C. 1H NMR (400 MHz,
CDCl3): δ ppm 7.78 (d, J = 8 Hz, 2H), 7.48−7.42 (m, 8H), 7.03 (d, J
= 8 Hz, 2H), 6.01 (s, 1H), 2.67−2.62 (m, 1H), 2.39−2.25 (m, 2H),
2.20−2.10 (m, 1H), 1.38 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3):
δ ppm 169.9, 154.1, 145.7, 138.9, 136.0, 132.0, 131.7, 131.6, 130.2,
131.7, 131.6, 130.2, 127.2, 126.9, 124.4, 123.6, 121.2, 51.3, 34.9, 31.2,
23.8, 18.6. HRMS (ESI-Q-TOF) exact mass calcd for C27H27Br2N2O
[M + H]+ 555.0472, found 555.0427.
1
75%) as a yellow solid. Mp = 187.5−188.3 °C. H NMR (400 MHz,
CDCl3): δ ppm 7.78 (d, J = 8 Hz, 2H), 7.53 (d, J = 8 Hz, 2H), 7.42
(d, J = 8 Hz, 2H), 7.08 (d, J = 8 Hz, 2H), 6.87−6.83 (m, 4H), 5.99 (s,
1H), 3.81 (s, 3H), 3.76 (s, 3H), 2.70−2.62 (m, 1H), 2.36−2.15 (m,
3H). 13C{1H} NMR (100 MHz, CDCl3): δ ppm 168.8, 160.6, 158.8,
147.3, 136.2, 133.8, 131.8, 131.6, 130.4, 129.7, 127.6, 126.8, 126.6,
114.3, 113.9, 55.4, 51.2, 24.1, 18.7. HRMS (ESI-Q-TOF) exact mass
calcd for C25H24ClN2O3 [M + H]+ 435.1476, found 435.1485.
(3,6-Bis(4-chlorophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-
chlorophenyl)methanone (4k). The representative procedure was
followed using 4-chloro-N′-(2-chloro-1-(4-chlorophenyl)ethylidene)-
benzohydrazide (1p) (0.5 mmol) as the substrate. Isolation by
column chromatography (PE/EtOAc: 5:1) yielded 4k (93 mg, 85%)
as a yellow solid. Mp = 195.8−197.0 °C. 1H NMR (400 MHz,
CDCl3): δ ppm 7.76 (d, J = 8 Hz, 2H), 7.50 (d, J = 8 Hz, 2H), 7.43
(d, J = 8 Hz, 2H), 7.32−7.28 (m, 4H), 7.08 (d, J = 8 Hz, 2H), 6.00 (s,
1H), 2.69−2.64 (m, 1H), 2.39−2.25 (m, 2H), 2.21−2.12 (m, 1H).
13C{1H} NMR (100 MHz, CDCl3): δ ppm 169.0, 146.4, 138.2, 136.7,
(4-(tert-Butyl)phenyl)(3,6-di([1,1′-biphenyl]-4-yl)-5,6-dihydropyr-
idazin-1(4H)-yl) Methanone (4p). The representative procedure was
followed using N′-(1-([1,1′-biphenyl]-4-yl)-2-bromoethylidene)-4-
(tert-butyl)benzohydrazide (1u) (0.2 mmol) as the substrate.
Isolation by column chromatography (PE/EtOAc: 5:1) yielded 4p
1
(121 mg, 89%) as a yellow solid. Mp = 189.2−190.4 °C. H NMR
(400 MHz, CDCl3): δ ppm 7.87 (d, J = 8 Hz, 2H), 7.72 (d, J = 8 Hz,
2H), 7.60−7.58 (m, 3H), 7.56−7.49 (m, 7H), 7.45−7.39 (m, 5H),
7.37−7.27 (m, 4H), 6.14 (s, 1H), 2.80−2.72 (m, 1H), 2.48−2.21 (m,
3H), 1.39 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ ppm 170.0,
153.8, 146.4, 141.9, 140.8, 140.4, 140.2, 139.1, 136.2, 132.1, 130.3,
128.8, 127.6, 127.2, 127.1, 127.0, 126.0, 125.9, 124.4, 51.7, 34.9, 31.3,
24.1, 18.9. HRMS (ESI-Q-TOF) exact mass calcd for C39H37N2O [M
+ H]+ 549.2906, found 549.2922.
(3,6-Bis(4-nitrophenyl)-5,6-dihydropyridazin-1(4H)-yl)(4-(tert-
butyl)phenyl)methanone (4q). The representative procedure was
followed using N′-(2-bromo-1-(4-nitrophenyl)ethylidene)-4-(tert-
butyl)benzohydrazide (1v) (0.2 mmol) as the substrate. Isolation
by column chromatography (PE/EtOAc: 5:1) yielded 4q (85 mg,
135.5, 135.2, 133.3, 131.6, 129.1, 128.8, 127.8, 126.6, 51.3, 23.8, 18.6.
HRMS (ESI-Q-TOF) exact mass calcd for C23H18Cl2N2O [M + H]+
443.0485, found 443.0491.
4,4′-(1-(4-Chlorobenzoyl)-1,4,5,6-tetrahydropyridazine-3,6-diyl)
1
Dibenzonitrile (4l). The representative procedure was followed using
70%) as a yellow solid. Mp = 70.2−72.3 °C. H NMR (400 MHz,
H
J. Org. Chem. XXXX, XXX, XXX−XXX